Skip to main content
Advertisement
Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study

December 1, 2022

Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study

In a retrospective cohort study from Canada, Dr Mary Kennedy and colleagues explore the effect of discontinuation and tapering of prescribed opioids on risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder.

Image credit: Towfiqu barbhuiya, Unsplash

PLOS Medicine is experiencing high submission volumes.

Processing of new submissions will restart in January 2023 as new staff are onboarded. We apologise for the delay.

11/07/2022

Research Article

Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study

In this multi-centre cohort study from Switzerland, Dr Christian R. Kahlert and colleagues investigate the risk and symptoms of COVID-19 among healthcare professionals, according to baseline immune status and booster vaccination, during the Delta and Omicron waves.

Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland—A multicentre cohort study

Image credit: Ashkan Forouzani, Unsplash

Get new content from PLOS Medicine in your inbox

Thank you! You have successfully subscribed to the PLOS Medicine newsletter.

Sorry, an error occurred while sending your subscription. Please try again later.

Try again
PLOS Medicine | ISSN: 1549-1676 (online)